Published in Kidney Int on February 01, 2004
Prevalence of kidney stones in the United States. Eur Urol (2012) 9.42
Kidney stone disease. J Clin Invest (2005) 3.45
Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol (2014) 2.28
Recent advances in the pathophysiology of nephrolithiasis. Kidney Int (2008) 2.26
Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant (2011) 1.87
History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol (2010) 1.84
Metabolism of fructose to oxalate and glycolate. Horm Metab Res (2010) 1.84
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
Nephrolithiasis. Prim Care (2008) 1.71
What is the stone-free rate following flexible ureteroscopy for kidney stones? Nat Rev Urol (2015) 1.55
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community. Mayo Clin Proc (2015) 1.44
Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41
Clinical significance of uric acid dihydrate in urinary stones. Urol Res (2010) 1.41
Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis (2014) 1.39
Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline. World J Urol (2005) 1.36
Influence of body size on urinary stone composition in men and women. Urol Res (2006) 1.36
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27
Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res (2004) 1.25
Metabolic syndrome in South Asians. Indian J Endocrinol Metab (2012) 1.24
Uric Acid nephrolithiasis: recent progress and future directions. Rev Urol (2007) 1.23
Stone composition as a function of age and sex. Clin J Am Soc Nephrol (2014) 1.15
Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother (2013) 1.14
Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12
Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. Am J Physiol Cell Physiol (2013) 1.10
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
Acid-base metabolism: implications for kidney stones formation. Urol Res (2006) 1.02
New insights into the pathogenesis of renal calculi. Urol Clin North Am (2012) 1.01
Association of body mass index and urine pH in patients with urolithiasis. Urol Res (2009) 0.99
Difference in urinary stone components between obese and non-obese patients. Urol Res (2010) 0.98
Epidemiology of stone disease across the world. World J Urol (2017) 0.92
Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One (2013) 0.92
Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metab Syndr Relat Disord (2011) 0.91
Type of renal calculi: variation with age and sex. World J Urol (2007) 0.91
Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. Urol Res (2011) 0.89
Infrared spectroscopic analysis of 5,248 urinary stones from Chinese patients presenting with the first stone episode. Urol Res (2011) 0.88
The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney Int (2012) 0.88
Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87
Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers. Urology (2015) 0.87
Dietary acid load and metabolic acidosis in renal transplant recipients. Clin J Am Soc Nephrol (2012) 0.87
Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr (2011) 0.86
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86
Metabolic diagnosis in stone formers in relation to body mass index. Urol Res (2011) 0.85
Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasis. Comp Med (2010) 0.85
Improvement of erectile function by Korean red ginseng (Panax ginseng) in a male rat model of metabolic syndrome. Asian J Androl (2013) 0.85
Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab (2008) 0.84
Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis. PLoS Genet (2011) 0.84
Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Miner Bone Metab (2008) 0.84
Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals. J Urol (2012) 0.83
The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis. Cent European J Urol (2014) 0.83
Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms. World J Nephrol (2012) 0.83
Flexible ureterorenoscopy (F-URS) with holmium laser versus extracorporeal shock wave lithotripsy (ESWL) for treatment of renal stone <2 cm: a meta-analysis. Urolithiasis (2015) 0.83
Plasma bicarbonate and odds of incident hypertension. Am J Hypertens (2013) 0.82
Possible Relationship between Metabolic Syndrome Traits and Nephrolithiasis: Incidence for 15 Years According to Gender. Korean J Urol (2011) 0.82
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol (2017) 0.82
Pharmacology of stone disease. Adv Chronic Kidney Dis (2009) 0.81
Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol (2013) 0.81
Bilateral urinary calculi with discordant stone composition. World J Urol (2013) 0.80
Epidemiology of pediatric urolithiasis. Indian J Urol (2010) 0.80
Pediatric urolithiasis: causative factors, diagnosis and medical management. Nat Rev Urol (2012) 0.79
Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis (2015) 0.79
Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder. Clin Rev Bone Miner Metab (2011) 0.79
Nephrolithiasis: Endocrine evaluation. Indian J Endocrinol Metab (2012) 0.79
Pathomechanisms of nephrolithiasis. Hippokratia (2013) 0.79
Effect of two sports drinks on urinary lithogenicity. Urol Res (2008) 0.79
The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol. Endocr Res (2010) 0.78
Metabolic syndrome, obesity and kidney stones. Arab J Urol (2012) 0.78
Treatment of patients with uric acid stones. Urolithiasis (2015) 0.77
Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. J Transl Med (2013) 0.77
Alkalizer administration improves renal function in hyperuricemia associated with obesity. Jpn Clin Med (2013) 0.77
Recent advances in managing and understanding nephrolithiasis/nephrocalcinosis. F1000Res (2016) 0.77
Type 2 diabetes mellitus and renal stones. Adv Biomed Res (2015) 0.77
Triuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniques. Arch Biochem Biophys (2010) 0.77
The association of metabolic syndrome and urolithiasis. Int J Endocrinol (2015) 0.77
Role of insulin resistance in uric acid nephrolithiasis. World J Nephrol (2014) 0.77
Is urolithiasis associated with increased levels of high sensitivity C-reactive protein and interleukin-6 in diabetic patients? J Clin Diagn Res (2015) 0.77
Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies. Urolithiasis (2015) 0.76
Stone formation and management after bariatric surgery. Nat Rev Urol (2015) 0.76
Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome. Urolithiasis (2013) 0.76
An Initial Attack of Urinary Stone Disease Is Associated with an Increased Risk of Developing New-Onset Irritable Bowel Syndrome: Nationwide Population-Based Study. PLoS One (2016) 0.76
Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis. Urol Res (2011) 0.76
Systemic implications of urinary stone disease. Transl Androl Urol (2012) 0.75
Metabolic syndrome and nephrolithiasis. Transl Androl Urol (2014) 0.75
Association Between Adiponectin and Insulin Resistance in Diabetic Urolithiasis. Oman Med J (2017) 0.75
Correlation between ApoE gene polymorphisms and the occurrence of urolithiasis. Exp Ther Med (2014) 0.75
Association between Dietary Acid Load and Insulin Resistance: Tehran Lipid and Glucose Study. Prev Nutr Food Sci (2016) 0.75
Comparison of Nephrolithiasis Prevalence in Two Bottlenose Dolphin (Tursiops truncatus) Populations. Front Endocrinol (Lausanne) (2013) 0.75
A comparison of the metabolic profiles of diabetic and non-diabetic uric acid stone formers. Can Urol Assoc J (2013) 0.75
Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL. Rev Urol (2009) 0.75
Diabetes mellitus and kidney stone formation. Rev Urol (2006) 0.75
Increased risk of acute coronary syndrome among patients with urinary stone disease: a nationwide population-based cohort study. PLoS One (2014) 0.75
The general practitioner and nephrolithiasis. Clin Cases Miner Bone Metab (2008) 0.75
Intraluminal measurement of papillary duct urine pH, in vivo: a pilot study in the swine kidney. Urolithiasis (2015) 0.75
Association between multiple chronic conditions and urolithiasis. Int Urol Nephrol (2017) 0.75
Metabolic evaluation of urinary lithiasis: what urologists should know and do. World J Urol (2014) 0.75
[Urinary calculi. Metabolism and diagnosis]. Urologe A (2006) 0.75
Compositional analysis of various layers of upper urinary tract stones by infrared spectroscopy. Exp Ther Med (2017) 0.75
Preventive Kidney Stones: Continue Medical Education. Int J Prev Med (2017) 0.75
Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis. J Urol (2015) 0.75
Uric acid stones following hepatic transplantation. Urol Res (2004) 0.75
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50
Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2008) 4.75
Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med (2010) 2.89
Association of urinary pH with body weight in nephrolithiasis. Kidney Int (2004) 2.67
Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int (2010) 2.50
Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23
The impact of ethnicity on type 2 diabetes. J Diabetes Complications (2002) 2.12
Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78
Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis (2002) 1.68
Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol (2003) 1.67
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab (2007) 1.66
Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66
Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Arch (2011) 1.63
Effect of dietary modification on urinary stone risk factors. Kidney Int (2005) 1.61
Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57
Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol (2005) 1.54
Hypercalciuria associated with high dietary protein intake is not due to acid load. J Clin Endocrinol Metab (2011) 1.54
Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Biochemical profile of stone-forming patients with diabetes mellitus. Urology (2003) 1.51
Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab (2004) 1.48
Etiological role of estrogen status in renal stone formation. J Urol (2002) 1.48
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46
Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44
ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes (2005) 1.43
Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41
Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40
Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol (2013) 1.39
Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. Diabetes Care (2006) 1.39
The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab (2008) 1.32
Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol (2005) 1.31
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27
The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27
Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26
Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A (2004) 1.23
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol (2010) 1.22
Ethnicity, type 2 diabetes & migrant Asian Indians. Indian J Med Res (2007) 1.21
Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21
Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol (2002) 1.20
Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20
Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab (2003) 1.19
Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf (2007) 1.19
Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19
Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. Mol Cell Proteomics (2008) 1.18
Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int (2004) 1.18
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab (2003) 1.17
Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract (2006) 1.14
Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13
Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. Am J Med Genet A (2007) 1.13
Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int (2002) 1.13
Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12
Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol (2004) 1.11
Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int (2003) 1.11
Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11
Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology (2007) 1.10
Ontogeny of NHE8 in the rat proximal tubule. Am J Physiol Renal Physiol (2007) 1.10
Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09
Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int (2010) 1.09
The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant (2012) 1.08
A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC). Proc Natl Acad Sci U S A (2007) 1.08
Role of ENPP1 on adipocyte maturation. PLoS One (2007) 1.07
Steady-state function of the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer coupling models with 2Na/2H stoichiometry. J Gen Physiol (2008) 1.07
Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol (2009) 1.07
Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol (2012) 1.06
Na+/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol (2006) 1.06
Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol (2011) 1.06
Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med (2002) 1.05
Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens (2005) 1.05
Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol (2005) 1.05
Renal and extrarenal actions of Klotho. Semin Nephrol (2013) 1.04
Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol Renal Physiol (2006) 1.04
Characterization of the sodium/hydrogen exchanger NHA2. J Am Soc Nephrol (2008) 1.02
Nephrolithiasis in topiramate users. Urol Res (2010) 1.01
Shank2 associates with and regulates Na+/H+ exchanger 3. J Biol Chem (2005) 1.01
Uric acid nephrolithiasis. Urol Clin North Am (2007) 1.01
Acute regulation of Na/H exchanger NHE3 by adenosine A(1) receptors is mediated by calcineurin homologous protein. J Biol Chem (2003) 1.00
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. Cardiovasc Diabetol (2014) 1.00
Postpneumonectomy lung expansion elicits hypoxia-inducible factor-1alpha signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.00